Population Pharmacokinetics and Safety of Dasatinib in Chinese Children with Core-Binding Factor Acute Myeloid Leukemia

被引：0
|
作者：
Fan Yang
Li Zhang
Bei-Bei Zhao
Jing-Liao Zhang
Xi-Ting Liu
Xue Li
Bo-Hao Tang
Yue Zhou
Xin-Mei Yang
John van den Anker
Xiao-Fan Zhu
Wei Zhao
机构：
[1] Shandong University,Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Pediatrics, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital
[3] The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital,Department of Clinical Pharmacy, Clinical Trial Center
[4] Shandong Engineering and Technology Research Center for Pediatric Drug Development,Division of Clinical Pharmacology
[5] Shandong Medicine and Health Key Laboratory of Clinical Pharmacy,Departments of Pediatrics, Pharmacology and Physiology, Genomics and Precision Medicine, School of Medicine and Health Sciences
[6] Children’s National Hospital,Department of Paediatric Pharmacology and Pharmacometrics, University Children’s Hospital Basel
[7] George Washington University,Department of Clinical Pharmacy, School of Pharmaceutical Sciences
[8] University of Basel,undefined
[9] Shandong University,undefined
来源：
Clinical Pharmacokinetics | 2022年 / 61卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：71 / 81
页数：10
相关论文
共 50 条
  • [31] Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta
    Cairoli, Roberto
    Beghini, Alessandro
    Turrini, Mauro
    Bertani, Giambattista
    Nadali, Gianpaolo
    Rodeghiero, Francesco
    Castagnola, Carlo
    Lazzaroni, Francesca
    Nichelatti, Michele
    Ferrara, Felicetto
    Pizzolo, Giovanni
    Pogliani, Enrico
    Rossi, Giuseppe
    Martinelli, Giovanni
    Morra, Enrica
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (07) : 594 - 600
  • [32] Granulocytic sarcoma of Core-binding Factor (CBF) acute myeloid leukemia mimicking pancreatic cancer
    Schaefer, Henning Sebastian
    Becker, Heiko
    Schmitt-Graeff, Annette
    Luebbert, Michael
    LEUKEMIA RESEARCH, 2008, 32 (09) : 1472 - 1475
  • [33] Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: A SEER database analysis
    Brunner, Andrew M.
    Blonquist, Traci M.
    Sadrzadeh, Hossein
    Perry, Ashley M.
    Attar, Eyal C.
    Amrein, Philip C.
    Ballen, Karen K.
    Chen, Yi-Bin
    Neuberg, Donna S.
    Fathi, Amir T.
    LEUKEMIA RESEARCH, 2014, 38 (07) : 773 - 780
  • [34] Core binding factor acute myeloid leukemia
    Mouchel, Pierre Luc
    HEMATOLOGIE, 2015, 21 (01): : 91 - 94
  • [35] Core binding factor acute myeloid leukemia
    Paschka, Peter
    SEMINARS IN ONCOLOGY, 2008, 35 (04) : 410 - 417
  • [36] Population Pharmacokinetics and Pharmacogenetics Analyses of Dasatinib in Chinese Patients with Chronic Myeloid Leukemia
    He, Shiyu
    Zhao, Jinxia
    Bian, Jialu
    Zhao, Yinyu
    Li, Yuanyuan
    Guo, Nan
    Hu, Lei
    Liu, Boyu
    Shao, Qianhang
    He, Huan
    Huang, Lin
    Jiang, Qian
    PHARMACEUTICAL RESEARCH, 2023, 40 (10) : 2413 - 2422
  • [37] Population Pharmacokinetics and Pharmacogenetics Analyses of Dasatinib in Chinese Patients with Chronic Myeloid Leukemia
    Shiyu He
    Jinxia Zhao
    Jialu Bian
    Yinyu Zhao
    Yuanyuan Li
    Nan Guo
    Lei Hu
    Boyu Liu
    Qianhang Shao
    Huan He
    Lin Huang
    Qian Jiang
    Pharmaceutical Research, 2023, 40 : 2413 - 2422
  • [38] Animal modeling of core-binding factor translocations reveals contrasting phenotypes in progression to acute myeloid leukemia
    Kim, H
    Ko, R
    de Guzman-Strong, C
    Hiebert, SW
    Klug, CA
    BLOOD CELLS MOLECULES AND DISEASES, 2004, 33 (02) : 110 - 110
  • [39] t(9;22) as secondary alteration in core-binding factor de novo acute myeloid leukemia
    Vitale, Candida
    Lu, Xinyan
    Abderrahman, Balkees
    Takahashi, Koichi
    Ravandi, Farhad
    Jabbour, Elias
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (11) : E211 - E212
  • [40] Multidrug resistance (MDR) in acute myeloid leukemia (AML) with core-binding factor (CBF) abnormalities.
    Baer, MR
    O'Loughlin, KL
    Minderman, H
    Sait, SN
    Flood, JJ
    Sorci, JJ
    Stewart, CC
    BLOOD, 1999, 94 (10) : 64A - 64A
12345